P-1667. Effect of Penicillin Allergy on Common Urinary Tract Pathogens within a Community Health-System Antibiogram

Abstract Background A penicillin allergy label promotes use of broad-spectrum and alternative antibiotics, which can cause an increase in resistance. Urinary tract infections are commonly encountered in health systems and few studies have shown how a documented penicillin allergy affects resistance on a yearly antibiogram for these isolates. Urinary Antibiogram for Penicillin and Non-penicillin Allergic PatientsTable 1lists Gram negative isolates for penicillin and non-penicillin allergic patients and Table 2 lists the Gram positive isolates Methods This was a retrospective, observational chart review of patients admitted in 2022 within a two-hospital community health-system. Using a query language server and third-party software, patients with a first positive bacterial culture were compared with those with a penicillin allergy to create distinct antibiograms. Data collected included culture site and organism, antibiotic susceptibility, and presence of an infectious diseases (ID) consultation. The primary outcome was percentage of susceptible and non-susceptible isolates of E. coli, P. mirabilis, K. pneumoniae, P. aeruginosa, and E. faecalis in penicillin allergic and non-penicillin allergic patients. A secondary outcome was to determine if ID consultation was different between subgroups. Chi-squared and student's t-test were used for categorical and continuous variables, respectively. Results Of 3,757 patients meeting inclusion criteria, 12.8% (n=484) were penicillin allergic with results in Table 1&2. E. coli had a significantly lower susceptibility rate for ciprofloxacin (p < 0.001), levofloxacin (p < 0.001), and trim/sulfa (p=0.002) in penicillin allergic patients. P. mirabilis had a significantly lower susceptibility rate for cefepime (p=0.015), gentamicin (p=0.006), levofloxacin (p=0.025), ciprofloxacin (p=0.023), and pip/tazo (p=0.012). K. pneumoniae showed higher susceptibility rates for multiple antibiotics in the penicillin allergic group. P. aeruginosa and E. faecalis did not show any statistically significant differences. There was ID consultation on 137/484 (28.3%) of penicillin allergic patients and 899/3273 (27.5%) of non-penicillin allergic patients, which was not statistically different (p=0.7719). Conclusion Labeled penicillin allergic patients demonstrated increased resistance in E. coli and P. mirabilis, while K. pneumoniae had higher resistance rates in non-allergic patients. Both groups had similarly high rates of ID consultation. Disclosures Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS, Merck: Honoraria|Nestle/Seres: Honoraria|Shionogi: Advisor/Consultant|Shionogi: Honoraria Bruce M. Jones, Pharm.D., FIDSA, BCPS, AbbVie: Advisor/Consultant|AbbVie: Honoraria|Ferring: Honoraria|Innoviva: Honoraria|Paratek: Honoraria

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-01-29
DOI
https://doi.org/10.1093/ofid/ofae631.1833
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1667. Effect of Penicillin Allergy on Common Urinary Tract Pathogens within a Community Health-System Antibiogram

Susan Smith, Logan C Bradley, Katherine Weller, Bruce M Jones et al.
Open Forum Infectious Diseases
Drug-Induced Adverse Reactions
article

P-1667. Effect of Penicillin Allergy on Common Urinary Tract Pathogens within a Community Health-System Antibiogram

Susan Smith, Logan C Bradley, Katherine Weller, Bruce M Jones, Christopher M. Bland
article en

Abstract

Abstract Background A penicillin allergy label promotes use of broad-spectrum and alternative antibiotics, which can cause an increase in resistance. Urinary tract infections are commonly encountered in health systems and few studies have shown how a documented penicillin allergy affects resistance on a yearly antibiogram for these isolates. Urinary Antibiogram for Penicillin and Non-penicillin Allergic PatientsTable 1lists Gram negative isolates for penicillin and non-penicillin allergic patients and Table 2 lists the Gram positive isolates Methods This was a retrospective, observational chart review of patients admitted in 2022 within a two-hospital community health-system. Using a query language server and third-party software, patients with a first positive bacterial culture were compared with those with a penicillin allergy to create distinct antibiograms. Data collected included culture site and organism, antibiotic susceptibility, and presence of an infectious diseases (ID) consultation. The primary outcome was percentage of susceptible and non-susceptible isolates of E. coli, P. mirabilis, K. pneumoniae, P. aeruginosa, and E. faecalis in penicillin allergic and non-penicillin allergic patients. A secondary outcome was to determine if ID consultation was different between subgroups. Chi-squared and student's t-test were used for categorical and continuous variables, respectively. Results Of 3,757 patients meeting inclusion criteria, 12.8% (n=484) were penicillin allergic with results in Table 1&2. E. coli had a significantly lower susceptibility rate for ciprofloxacin (p < 0.001), levofloxacin (p < 0.001), and trim/sulfa (p=0.002) in penicillin allergic patients. P. mirabilis had a significantly lower susceptibility rate for cefepime (p=0.015), gentamicin (p=0.006), levofloxacin (p=0.025), ciprofloxacin (p=0.023), and pip/tazo (p=0.012). K. pneumoniae showed higher susceptibility rates for multiple antibiotics in the penicillin allergic group. P. aeruginosa and E. faecalis did not show any statistically significant differences. There was ID consultation on 137/484 (28.3%) of penicillin allergic patients and 899/3273 (27.5%) of non-penicillin allergic patients, which was not statistically different (p=0.7719). Conclusion Labeled penicillin allergic patients demonstrated increased resistance in E. coli and P. mirabilis, while K. pneumoniae had higher resistance rates in non-allergic patients. Both groups had similarly high rates of ID consultation. Disclosures Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS, Merck: Honoraria|Nestle/Seres: Honoraria|Shionogi: Advisor/Consultant|Shionogi: Honoraria Bruce M. Jones, Pharm.D., FIDSA, BCPS, AbbVie: Advisor/Consultant|AbbVie: Honoraria|Ferring: Honoraria|Innoviva: Honoraria|Paratek: Honoraria

Open Forum Infectious DiseasesVol. 12(Supplement_1)
Georgia College & State University (US), Savannah State University (US), University of Georgia (US), Savannah Technical College (US), St. Joseph’s Candler Hospital (US), First Candle (US)
Openalex Percentile: Top 98%
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.